Búsqueda | Biblioteca Virtual en Salud

1.

Mutations of the BCR-ABL-kinase domain occur in a minority of patients with stable complete cytogenetic response to imatinib.

Sherbenou, D W; Wong, M J; Humayun, A; McGreevey, L S; Harrell, P; Yang, R; Mauro, M; Heinrich, M C; Press, R D; Druker, B J; Deininger, M W.

Leukemia ; 21(3): 489-93, 2007 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-17252009

2.

Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results.

Gomez, P S; Parks, S; Ries, R; Tran, T C; Gomez, P F; Press, R D.

Nat Genet ; 23(3): 272, 1999 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-10545944

3.

Overexpression of C-terminally but not N-terminally truncated Myb induces fibrosarcomas: a novel nonhematopoietic target cell for the myb oncogene.

Press, R D; Reddy, E P; Ewert, D L.

Mol Cell Biol ; 14(4): 2278-90, 1994 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-8139533

4.

Control of the expression of c-sis mRNA in human glioblastoma cells by phorbol ester and transforming growth factor beta 1.

Press, R D; Misra, A; Gillaspy, G; Samols, D; Goldthwait, D A.

Cancer Res ; 49(11): 2914-20, 1989 Jun 01.

Artículo en Inglés | MEDLINE | ID: mdl-2655888

5.

Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale.

Cross, N C P; White, H E; Ernst, T; Welden, L; Dietz, C; Saglio, G; Mahon, F-X; Wong, C C; Zheng, D; Wong, S; Wang, S-S; Akiki, S; Albano, F; Andrikovics, H; Anwar, J; Balatzenko, G; Bendit, I; Beveridge, J; Boeckx, N; Cerveira, N; Cheng, S-M; Colomer, D; Czurda, S; Daraio, F; Dulucq, S; Eggen, L; El Housni, H; Gerrard, G; Gniot, M; Izzo, B; Jacquin, D; Janssen, J J W M; Jeromin, S; Jurcek, T; Kim, D-W; Machova-Polakova, K; Martinez-Lopez, J; McBean, M; Mesanovic, S; Mitterbauer-Hohendanner, G; Mobtaker, H; Mozziconacci, M-J; Pajic, T; Pallisgaard, N; Panagiotidis, P; Press, R D; Qin, Y-Z; Radich, J; Sacha, T; Touloumenidou, T.

Leukemia ; 30(9): 1844-52, 2016 09.

Artículo en Inglés | MEDLINE | ID: mdl-27109508

6.

Induction of B cell lymphomas by overexpression of a Myb oncogene truncated at either terminus.

Press, R D; Wisner, T W; Ewert, D L.

Oncogene ; 11(3): 525-35, 1995 Aug 03.

Artículo en Inglés | MEDLINE | ID: mdl-7630637

7.

Real-time polymerase chain reaction with fluorescent hybridization probes for the detection of prevalent mutations causing common thrombophilic and iron overload phenotypes.

Parks, S B; Popovich, B W; Press, R D.

Am J Clin Pathol ; 115(3): 439-47, 2001 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-11242801

8.

Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis.

Press, R D; Flora, K; Gross, C; Rabkin, J M; Corless, C L.

Am J Clin Pathol ; 109(5): 577-84, 1998 May.

Artículo en Inglés | MEDLINE | ID: mdl-9576576

9.

Role of a common mutation in the homocysteine regulatory enzyme methylenetetrahydrofolate reductase in ischemic stroke.

Press, R D; Beamer, N; Evans, A; DeLoughery, T G; Coull, B M.

Diagn Mol Pathol ; 8(1): 54-8, 1999 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-10408794

10.

Molecular detection of a common mutation in coagulation factor V causing thrombosis via hereditary resistance to activated protein C.

Liu, X Y; Nelson, D; Grant, C; Morthland, V; Goodnight, S H; Press, R D.

Diagn Mol Pathol ; 4(3): 191-7, 1995 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-7493138

11.

Hereditary hemochromatosis: impact of molecular and iron-based testing on the diagnosis, treatment, and prevention of a common, chronic disease.

Press, R D.

Arch Pathol Lab Med ; 123(11): 1053-9, 1999 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-10539907

12.

Preliminary CLIAC recommendations to regulate genetic testing.

Press, R D.

Mol Diagn ; 5(3): 245-7, 2000 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-11151838

13.

Thrombophilic mutations impart a high risk of pregnancy-related venous thrombosis.

Press, R D.

Mol Diagn ; 5(2): 158, 2000 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-11066018

14.

Human Papillomavirus DNA detection for cervical cancer screening.

Press, R D.

Mol Diagn ; 5(3): 245-7, 2000 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-11186127

15.

Clinical news update.

Press, R D.

Mol Diagn ; 5(4): 359-61, 2000 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-11172500

16.

Exclusivity in testing for patented disease genes.

Press, R D.

Mol Diagn ; 4(1): 72-3, 1999 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-10438236

17.

Analyte-specific reagents.

Press, R D.

Mol Diagn ; 4(1): 71, 1999 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-10229777

18.

Subspecialty certification examination in molecular genetic pathology.

Press, R D.

Mol Diagn ; 4(3): 255, 1999 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-10644171

19.

Food and Drug Administration approval for 2 new molecular infectious disease assays.

Press, R D.

Mol Diagn ; 4(3): 256, 1999 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-10644172

20.

GeneClinics Medical Genetics Knowledge Base.

Press, R D.

Mol Diagn ; 4(3): 256, 1999 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-10644173

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

Mutations of the BCR-ABL-kinase domain occur in a minority of patients with stable complete cytogenetic response to imatinib.

Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results.

Overexpression of C-terminally but not N-terminally truncated Myb induces fibrosarcomas: a novel nonhematopoietic target cell for the myb oncogene.

Control of the expression of c-sis mRNA in human glioblastoma cells by phorbol ester and transforming growth factor beta 1.

Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale.

Induction of B cell lymphomas by overexpression of a Myb oncogene truncated at either terminus.

Real-time polymerase chain reaction with fluorescent hybridization probes for the detection of prevalent mutations causing common thrombophilic and iron overload phenotypes.

Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis.

Role of a common mutation in the homocysteine regulatory enzyme methylenetetrahydrofolate reductase in ischemic stroke.

Molecular detection of a common mutation in coagulation factor V causing thrombosis via hereditary resistance to activated protein C.

Hereditary hemochromatosis: impact of molecular and iron-based testing on the diagnosis, treatment, and prevention of a common, chronic disease.

Preliminary CLIAC recommendations to regulate genetic testing.

Thrombophilic mutations impart a high risk of pregnancy-related venous thrombosis.

Human Papillomavirus DNA detection for cervical cancer screening.

Clinical news update.

Exclusivity in testing for patented disease genes.

Analyte-specific reagents.

Subspecialty certification examination in molecular genetic pathology.

Food and Drug Administration approval for 2 new molecular infectious disease assays.

GeneClinics Medical Genetics Knowledge Base.